Exane Derivatives Medifast Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Medifast Inc stock. As of the latest transaction made, Exane Derivatives holds 2 shares of MED stock, worth $37. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 524
99.62%
Holding current value
$37
Previous $89,000
100.0%
% of portfolio
0.0%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding MED
# of Institutions
178Shares Held
10.4MCall Options Held
554KPut Options Held
545K-
Jim Simons Renaissance Technologies LLC | New York, Ny959KShares$17.8 Million0.04% of portfolio
-
Black Rock Inc. New York, NY829KShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA723KShares$13.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny469KShares$8.72 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT390KShares$7.25 Million0.01% of portfolio
About MEDIFAST INC
- Ticker MED
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Personal Services
- Shares Outstandng 11,017,900
- Market Cap $205M
- Description
- Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...